Bogart Wealth, LLC Abb Vie Inc. Transaction History

Bogart Wealth, LLC

$2.1 Billion
Q3 2024

A detailed history of Bogart Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bogart Wealth, LLC holds 3,720 shares of ABBV stock, worth $669,600. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,720

Previous 3,805 2.23%

Holding current value

$669,600

Previous $652,000 12.58%

% of portfolio

0.03%

Previous 0.03%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$163.84 - $199.33 $13,926 - $16,943	-85 Reduced 2.23%	3,720 $734,000
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $154,480 - $180,398	-998 Reduced 20.78%	3,805 $652,000
Q1 2024 Apr 25, 2024	SELL	$159.82 - $182.1 $8.79 Million - $10 Million	-55,008 Reduced 91.97%	4,803 $874,000
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $146,406 - $164,888	-1,064 Reduced 1.75%	59,811 $9.27 Million
Q3 2023 Oct 30, 2023	SELL	$133.59 - $154.65 $11,889 - $13,763	-89 Reduced 0.15%	60,875 $9.07 Million
Q2 2023 Jul 28, 2023	BUY	$132.51 - $164.9 $83,216 - $103,557	628 Added 1.04%	60,964 $8.21 Million
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $1.8 Million - $2.07 Million	-12,413 Reduced 17.06%	60,336 $9.62 Million
Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $607,872 - $728,998	4,395 Added 6.43%	72,749 $11.8 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $1.39 Million - $1.6 Million	10,388 Added 17.92%	68,354 $9.17 Million
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $1.27 Million - $1.62 Million	9,262 Added 19.02%	57,966 $8.88 Million
Q1 2022 Apr 22, 2022	SELL	$131.98 - $163.75 $1.12 Million - $1.39 Million	-8,484 Reduced 14.84%	48,704 $7.9 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $277,276 - $350,835	2,581 Added 4.73%	57,188 $7.74 Million
Q3 2021 Oct 15, 2021	BUY	$106.4 - $120.78 $318,774 - $361,856	2,996 Added 5.8%	54,607 $5.89 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $655,879 - $730,687	6,234 Added 13.74%	51,611 $5.81 Million
Q1 2021 Apr 16, 2021	BUY	$102.3 - $112.62 $1.06 Million - $1.17 Million	10,386 Added 29.68%	45,377 $4.91 Million
Q4 2020 Jan 14, 2021	BUY	$80.49 - $108.67 $154,460 - $208,537	1,919 Added 5.8%	34,991 $3.75 Million
Q3 2020 Oct 06, 2020	SELL	$85.91 - $100.83 $55,497 - $65,136	-646 Reduced 1.92%	33,072 $2.9 Million
Q2 2020 Jul 08, 2020	SELL	$73.37 - $98.18 $12,546 - $16,788	-171 Reduced 0.5%	33,718 $3.31 Million
Q1 2020 Apr 20, 2020	SELL	$64.5 - $97.79 $132,160 - $200,371	-2,049 Reduced 5.7%	33,889 $2.58 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $53,953 - $67,507	748 Added 2.13%	35,938 $3.18 Million
Q3 2019 Oct 10, 2019	BUY	$62.98 - $75.72 $125,834 - $151,288	1,998 Added 6.02%	35,190 $2.67 Million
Q2 2019 Jul 11, 2019	BUY	$65.7 - $83.98 $270,881 - $346,249	4,123 Added 14.18%	33,192 $2.41 Million
Q1 2019 Apr 08, 2019	BUY	$77.14 - $90.79 $526,326 - $619,460	6,823 Added 30.67%	29,069 $2.34 Million
Q4 2018 Jan 15, 2019	BUY	$77.85 - $96.01 $48,811 - $60,198	627 Added 2.9%	22,246 $2.05 Million
Q3 2018 Oct 16, 2018	BUY	$88.91 - $98.84 $163,060 - $181,272	1,834 Added 9.27%	21,619 $2.05 Million
Q2 2018 Jul 13, 2018	BUY	$89.78 - $106.23 $70,297 - $83,178	783 Added 4.12%	19,785 $1.83 Million
Q1 2018 Apr 13, 2018	BUY	$92.01 - $123.21 $120,993 - $162,021	1,315 Added 7.43%	19,002 $1.75 Million
Q4 2017 Jan 11, 2018	SELL	$89.56 - $98.21 $529,657 - $580,813	-5,914 Reduced 25.06%	17,687 $1.71 Million
Q3 2017 Oct 12, 2017	SELL	$69.85 - $89.22 $58,534 - $74,766	-838 Reduced 3.43%	23,601 $2.14 Million
Q2 2017 Sep 19, 2017	BUY	N/A	6,491 Added 36.17%	24,439 $1.77 Million
Q1 2017 Sep 19, 2017	BUY	N/A	1,528 Added 9.31%	17,948 $1.17 Million
Q4 2016 Aug 31, 2017	BUY	N/A	16,420	16,420 $1.03 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bogart Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bogart Wealth, LLC with notifications on news.

Account

Bogart Wealth, LLC Abb Vie Inc. Transaction History